Skip to main content

Table 1 Patient baseline characteristics by history of injection drug use

From: An application of restricted mean survival time in a competing risks setting: comparing time to ART initiation by injection drug use

 

N (%)

 

Persons who did not inject drugs

N = 1889 (62.1%)

PWID

N = 1155 (37.9%)

Total

N = 3044

Age, median (IQR)

38.2 (31.4–45.3)

41.2 (36.7–46.4)

39.5 (33.7–45.8)

Sex

 Female

655 (34.7)

403 (34.9)

1058 (34.8)

 Male

1234 (65.3)

752 (65.1)

1986 (65.2)

Race

 Black

1395 (73.8)

955 (82.7)

2350 (77.2)

 White

415 (22.0)

184 (15.9)

599 (19.7)

 Other

79 (4.2)

16 (1.4)

95 (3.1)

CD4, median (IQR)

280 (89–478)

279 (103–485)

279.5 (94–480)

Log10 RNA, median, (IQR)

4.7 (3.9–5.3)

4.6 (3.8–5.2)

4.6 (3.9–5.2)

Prior AIDS

 Yes

411 (21.8)

261 (22.6)

672 (22.1)

 No

1478 (78.2)

894 (77.4)

2372 (77.9)

Prior ART

 Yes

431 (22.8)

357 (30.9)

788 (25.9)

 No

1458 (77.2)

798 (69.1)

2256 (74.1)

Year of clinic enrollment

 1996–2001

971 (51.4)

787 (68.1)

1758 (57.8)

 2002–2007

468 (24.8)

222 (19.2)

690 (22.7)

 2008–2014

450 (23.8)

146 (12.6)

596 (19.6)

  1. Abbreviations: ART, antiretroviral therapy, IQR interquartile range, PWID, persons who inject drugs